AdvaMed Advancements / Artificial Intelligence (AI) / Coverage & Payment / Diabetes / Diagnostics / Digital Health / Global & Trade / Health Access / Investor Relations / Medical Imaging / Orthopedic / Regulatory Affairs / Tariffs / The MedTech Conference / Value-Based Collaborations

AdvaMed Concludes Record-Breaking MedTech Conference 2026

BOSTON—AdvaMed, the Medtech Association, concluded The MedTech Conference 2026, convening more than 4,470 attendees from 2,050 companies from 40 countries for the global medtech industry’s premier annual gathering.

Coverage & Payment / Regulatory Affairs

AdvaMed® Comments on FDA-2016-D-1307 Communications with Payors

AdvaMed’s recent submission to the Food and Drug Administration (FDA) provides comments on the Agency’s revised draft guidance governing communications between drug and device manufacturers and payors, formulary committees, and…

Coverage & Payment / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access / Regulatory Affairs

AdvaMed Statement on the Klomp Nomination

WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the largest trade association representing medtech innovators, posted his statement on LinkedIn regarding the nomination of Chris Klomp as deputy secretary of the…

Coverage & Payment / Government & Legislative Affairs / Health Access / Regulatory Affairs

A Policy Win for Maternal Health Innovation Throug FDA-CMS Collaboration

The United States faces a maternal health crisis demanding urgent action. The U.S. has the worst maternal outcomes among high income nations. Our maternal mortality rates far exceed peer countries’,…